BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 33326154)

  • 1. Extracellular water to total body water ratio obtained by bioelectrical impedance analysis determines the dose intensity of lenvatinib for the treatment of patients with advanced hepatocellular carcinoma.
    Yamaoka K; Kodama K; Hiramatsu A; Ando Y; Kosaka Y; Suehiro Y; Fujii Y; Uchikawa S; Morio K; Fujino H; Nakahara T; Murakami E; Yamauchi M; Kawaoka T; Miki D; Tsuge M; Imamura M; Takahashi S; Chayama K; Aikata H
    J Gastroenterol Hepatol; 2021 Jun; 36(6):1685-1693. PubMed ID: 33326154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The importance of body composition assessment for patients with advanced hepatocellular carcinoma by bioelectrical impedance analysis in lenvatinib treatment.
    Yamaoka K; Kodama K; Kawaoka T; Kosaka M; Johira Y; Shirane Y; Miura R; Yano S; Murakami S; Amioka K; Naruto K; Ando Y; Kosaka Y; Uchikawa S; Uchida T; Fujino H; Nakahara T; Murakami E; Okamoto W; Yamauchi M; Miki D; Imamura M; Takahashi S; Nagao A; Chayama K; Aikata H
    PLoS One; 2022; 17(1):e0262675. PubMed ID: 35041693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relative dose intensity over the first four weeks of lenvatinib therapy is a factor of favorable response and overall survival in patients with unresectable hepatocellular carcinoma.
    Kirino S; Tsuchiya K; Kurosaki M; Kaneko S; Inada K; Yamashita K; Osawa L; Hayakawa Y; Sekiguchi S; Okada M; Wang W; Higuchi M; Takaura K; Maeyashiki C; Tamaki N; Yasui Y; Nakanishi H; Itakura J; Takahashi Y; Asahina Y; Izumi N
    PLoS One; 2020; 15(4):e0231828. PubMed ID: 32310967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Relative Dose Intensity of Early-phase Lenvatinib Treatment on Therapeutic Response in Hepatocellular Carcinoma.
    Takahashi A; Moriguchi M; Seko Y; Ishikawa H; Yo T; Kimura H; Fujii H; Shima T; Mitsumoto Y; Ishiba H; Takashima H; Nagao Y; Jo M; Arai M; Hara T; Okajima A; Muramatsu A; Morita A; Yoshinami N; Nakajima T; Mitsuyoshi H; Umemura A; Nishikawa T; Yamaguchi K; Itoh Y
    Anticancer Res; 2019 Sep; 39(9):5149-5156. PubMed ID: 31519627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Association Between Extracellular Water-to-Total Body Water Ratio and Therapeutic Durability for Advanced Lung Cancer.
    Noda Y; Suzuki H; Kanai T; Samejima Y; Nasu S; Tanaka A; Morishita N; Okamoto N; Hirashima T
    Anticancer Res; 2020 Jul; 40(7):3931-3937. PubMed ID: 32620634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using dilution techniques and multifrequency bioelectrical impedance to assess both total body water and extracellular water at baseline and during recombinant human growth hormone (GH) treatment in GH-deficient adults.
    Janssen YJ; Deurenberg P; Roelfsema F
    J Clin Endocrinol Metab; 1997 Oct; 82(10):3349-55. PubMed ID: 9329367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracellular Water-to-total Body Water Ratio as an Objective Biomarker for Frailty in Lung Cancer Patients.
    Hirashima T; Noda Y; Suzuki H; Nasu S; Tanaka A; Morishita N; Ryota N; Iwata K; Okada Y; Okamoto N
    Anticancer Res; 2021 Mar; 41(3):1655-1662. PubMed ID: 33788762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Early Lenvatinib Administration on Survival in Patients with Intermediate-Stage Hepatocellular Carcinoma: A Multicenter, Inverse Probability Weighting Analysis.
    Tada T; Kumada T; Hiraoka A; Michitaka K; Atsukawa M; Hirooka M; Tsuji K; Ishikawa T; Takaguchi K; Kariyama K; Itobayashi E; Tajiri K; Shimada N; Shibata H; Ochi H; Yasuda S; Toyoda H; Fukunishi S; Ohama H; Kawata K; Nakamura S; Nouso K; Tsutsui A; Nagano T; Itokawa N; Okubo T; Arai T; Imai M; Joko K; Koizumi Y; Hiasa Y;
    Oncology; 2021; 99(8):518-527. PubMed ID: 33906189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase 2 study of lenvatinib in patients with advanced hepatocellular carcinoma.
    Ikeda K; Kudo M; Kawazoe S; Osaki Y; Ikeda M; Okusaka T; Tamai T; Suzuki T; Hisai T; Hayato S; Okita K; Kumada H
    J Gastroenterol; 2017 Apr; 52(4):512-519. PubMed ID: 27704266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Analysis of Muscle Volume Measured by Bioelectrical Impedance in Patients with Hepatocellular Carcinoma Treated with First-Line Atezolizumab plus Bevacizumab Combination Therapy or First-Line Lenvatinib.
    Chihiro K; Kawaoka T; Uchikawa S; Kinami T; Yamasaki S; Kosaka M; Johira Y; Yano S; Amioka K; Naruto K; Ando Y; Yamaoka K; Teraoka Y; Uchida T; Fujino H; Nakahara T; Ono A; Murakami E; Okamoto W; Yamauchi M; Miki D; Tsuge M; Imamura M; Aikata H; Oka S
    Oncology; 2023; 101(8):491-501. PubMed ID: 37429266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of body composition using dry mass index and ratio of total body water to estimated volume based on bioelectrical impedance analysis in chronic kidney disease patients.
    Ohashi Y; Otani T; Tai R; Tanaka Y; Sakai K; Aikawa A
    J Ren Nutr; 2013 Jan; 23(1):28-36. PubMed ID: 22406124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of body water distribution in patients with sepsis during fluid resuscitation using multi-frequency direct segmental bioelectrical impedance analysis.
    Park I; Lee JH; Jang DH; Kim J; Hwang BR; Kim S; Lee JE; Jo YH
    Clin Nutr; 2020 Jun; 39(6):1826-1831. PubMed ID: 31416662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracellular water to total body water ratio may mediate the association between phase angle and mortality in patients with cancer cachexia: A single-center, retrospective study.
    Katsura N; Yamashita M; Ishihara T
    Clin Nutr ESPEN; 2021 Dec; 46():193-199. PubMed ID: 34857195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prediction of total body water and extracellular water from bioelectric impedance in obese children.
    Bedogni G; Bollea MR; Severi S; Trunfio O; Manzieri AM; Battistini N
    Eur J Clin Nutr; 1997 Mar; 51(3):129-33. PubMed ID: 9076401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose Finding of Lenvatinib in Subjects With Advanced Hepatocellular Carcinoma Based on Population Pharmacokinetic and Exposure-Response Analyses.
    Tamai T; Hayato S; Hojo S; Suzuki T; Okusaka T; Ikeda K; Kumada H
    J Clin Pharmacol; 2017 Sep; 57(9):1138-1147. PubMed ID: 28561918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered body water distribution in subjects with juvenile rheumatoid arthritis and its effects on the measurement of water compartments from bioelectric impedance.
    Bedogni G; Polito C; Severi S; Strano CG; Manzieri AM; Alessio M; Iovene A; Battistini N
    Eur J Clin Nutr; 1996 Jun; 50(6):335-9. PubMed ID: 8793411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracellular Water to Total Body Water Ratio in Viral Liver Diseases: A Study Using Bioimpedance Analysis.
    Nishikawa H; Yoh K; Enomoto H; Ishii N; Iwata Y; Nakano C; Takata R; Nishimura T; Aizawa N; Sakai Y; Ikeda N; Hasegawa K; Takashima T; Iijima H; Nishiguchi S
    Nutrients; 2018 Aug; 10(8):. PubMed ID: 30103528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of 8 weeks' relative dose intensity of lenvatinib in treatment of radioiodine-refractory differentiated thyroid cancer patients.
    Fukuda N; Toda K; Wang X; Ohmoto A; Hayashi N; Urasaki T; Sato Y; Nakano K; Ono M; Tomomatsu J; Mitani H; Takahashi S
    Endocr J; 2021 Jun; 68(6):639-647. PubMed ID: 33504716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Body water distribution in severe obesity and its assessment from eight-polar bioelectrical impedance analysis.
    Sartorio A; Malavolti M; Agosti F; Marinone PG; Caiti O; Battistini N; Bedogni G
    Eur J Clin Nutr; 2005 Feb; 59(2):155-60. PubMed ID: 15340370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factor of lenvatinib for unresectable hepatocellular carcinoma in real-world conditions-Multicenter analysis.
    Hiraoka A; Kumada T; Atsukawa M; Hirooka M; Tsuji K; Ishikawa T; Takaguchi K; Kariyama K; Itobayashi E; Tajiri K; Shimada N; Shibata H; Ochi H; Tada T; Toyoda H; Nouso K; Tsutsui A; Nagano T; Itokawa N; Hayama K; Imai M; Joko K; Koizumi Y; Hiasa Y; Michitaka K; Kudo M;
    Cancer Med; 2019 Jul; 8(8):3719-3728. PubMed ID: 31127698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.